Dr Tamsyn Van Rheenen — Co-chair
Dr Tamsyn Van Rheenen is a post-doctoral research fellow working in the area of cognitive neuropsychiatry. Her research aims to use an understanding of neurobehavioral function and neurobiology to discover and validate biomarkers, improve diagnostic accuracy/risk identification and inform the development of novel treatment interventions for bipolar disorder.
Tamsyn graduated from Swinburne University in 2009 with a Bachelor of Social Science succeeded by an honours degree in Psychology. She commenced her PhD at Swinburne University in April 2010, after receiving an Australian Postgraduate Award to complete her research into cognition and emotion processing in bipolar disorder. Her thesis was passed in March 2014.
Tamsyn has recently been awarded a Peter Doherty Biomedical early career research fellowship from the NHMRC. She has also been the recipient of substantial travel funding to support her to present her work at several national and international conferences. The research she has been involved with has been featured in the in various news outlets (e.g., Medwire News, ABC Science, Nature World News, Psychiatry Weekly) and she has been recognized with several prestigious awards including an Australian Schizophrenia Conference Young Investigator Award for Research Excellence and a 2014 Australian Psychological Society Award for Excellent PhD thesis in Psychology.
Follow Tamsyn on Twitter — https://twitter.com/TamsynVR
Dr Emma Gliddon is an Associate Research Fellow from the IMPACT Strategic Research Centre at Deakin University. She is working on the NIMH-funded randomised controlled trial evaluating the MoodSwings online intervention for bipolar disorder (www.moodswings.net.au). She recently completed her PhD which investigated the use of online forums for bipolar disorder, and also currently works with DepressioNet on peer support forums for depression. She was the inaugural recipient of the Ian Parker Bipolar Research Fund/Australian Rotary Health PhD scholarship.
Emma is also the liason for this portion of the ASBDD website. Please direct any questions to firstname.lastname@example.org
Follow Emma on Twitter — https://twitter.com/eglidd
Dr Olivia Dean — Committee Member
Olivia Dean is currently the Director of the Clinical Trials Division of the Innovations in Mental and Physical Health and Clinical Treatments Strategic Research Centre (IMPACT SRC). During her research career, Dr. Dean has been responsible for the development and coordination of several successful multi-centre national and international randomized controlled trials. Dr Dean is currently overseeing the coordination of several clinical trials, two of which are currently NHMRC funded. Dr Dean has attracted over 4 million dollars in research funding, as a Chief and Co- Investigator. She has published over 50 journal articles and 2 book chapters.
In addition to her role directing the current clinical trials, Dr. Dean has broad research interests, focused on oxidative and inflammatory biology in psychiatric illness and has an interest in cognitive functioning. She is currently involved in several areas of research including oxidative biology and autism, inflammation and depression, mitochondrial dysfunction in bipolar disorder, and investigations of molecular markers of psychiatric illness (including oxidative and inflammatory markers). Her research program includes collaborations with a multitude of research groups including groups in Australia, France, South Africa, Thailand, Brazil, Portugal and Denmark.
Dr Frank Giorlando — Committee Member
Dr Frank Giorlando is a medical doctor and researcher investigating the perception of time. His research focuses upon integrating basic neuroscience with the psychiatry of dissociation. He is studying at the University of Melbourne and has also been a visiting scholar at the University of Cambridge. His current research includes studies of patients with Bipolar Disorder using the methodologies of psychophysics, computer modelling, MRI and EEG. Frank is a recepient of a Melbourne Research Scholarship and has received grants from the RANZCP, The University of Sydney, ASBDD/Astra Zeneca and Pfizer. He is also working on a theory integrating theoretical physics with non-dualist theory of consciousness.
Dr Lana Williams — Committee Member
Dr Lana Williams is a NHMRC Career Development Fellow and Psychologist with significant experience in psychiatric epidemiology and a special interest in the co-occurrence of physical and mental disorders. She currently is the Head of the Division of Psychiatric Epidemiology within the IMPACT Strategic Research Centre, Deakin University, and also leads GOS Mental Health, a large epidemiological study involving an age-stratified, random, population-based sample of ~3000 men and women. Over the past years, Dr Williams has been developing an innovative program of research examining medical, lifestyle and social correlates of mood, anxiety and personality disorders within the community. Cornerstone is her work investigating the interplay between psychiatric disorders, the medications used to treat these disorders and bone health, which has attracted extensive project funding and personal awards. Her research program is an invaluable resource for collaborative studies, both nationally and internationally and student projects.
Follow Lana on Twitter — https://twitter.com/lana_j_williams
Trung is currently an Honorary Fellow in the Neurosciences & Cognitive Health program at Mater Research Institute-UQ. He completed a PhD in Neuroscience with Jack Pettigrew, employing caloric vestibular stimulation (CVS) — a simple, non-invasive (unihemispheric) brain stimulation technique — to demonstrate evidence for a novel neural mechanism of visual rivalry: the interhemispheric switch model. At Monash Alfred Psychiatry Research Centre, his NHMRC postdoctoral clinical research fellowship focused on investigating rivalry mechanisms and abnormalities in psychiatric groups. Trung’s fellowship studies also examined CVS as a potential therapeutic intervention in persistent (chronic) pain disorders.
He is continuing this body of work with research projects into: (i) novel visual task measures for identifying individuals at increased risk of developing mental illness (e.g., young people, at-risk/early psychosis cohorts); (ii) the effectiveness of non-invasive vestibular neuromodulation (NVN) as a treatment for depression and related conditions; and (iii) the genetics and neuroimaging of therapeutic response to NVN, with the aim of elucidating novel electroceutical pathways, response biomarkers and personalised treatment protocols across a spectrum psychiatric and neurological disorders (‘electroceutomics’).
His other broad research interest entails the thesis that bistable (anti-phase) interhemispheric oscillations are a fundamental neurobiological mechanism — given they’re widely observed in several species (e.g., rodents, birds, cetaceans, humans, Drosophila) and across diverse phenotypes such as biological rhythms (e.g., sleep/wake and menstrual cycles), autonomic functions, oculomotor activity, perception/attention and mood/behaviour changes. Studies in this area will aim to determine whether the underlying genes, neural network dynamics (e.g., vestibulocortical circuitry) and molecular mechanisms are conserved in nature, with significant implications for translational outcomes across psychiatry, neurology and sleep medicine.